\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\\.\ \(1\)\
\-\ patient\\ had\\ an\\ immediate\\ post\\-op\\ mr\\ to\\ confirm\\ resolution\\ of\\ the\\ mass\\ effect\\.\\ \\ these\\ tumors\\ are\\ less\\ aggressive\\ and\\ have\\ a\\ good\\ surgical\\ cure\\ rate\\ but\\ recurrence\\ is\\ possible\\ so\\ he\\ will\\ need\\ survellience\\ mr\\ imaging\\.\ \(0\)\
\-\ ct\\-\\ within\\ the\\ posterior\\ right\\ frontal\\-parietal\\ region\\ there\\ is\\ a\\ large\\ heterogeneous\\ cystic\\ mass\\ measuring\\ \\~7\\.0\\ x\\ 5\\.0\\ cm\\.\\ \\ there\\ is\\ a\\ 3\\.0\\ x\\ 2\\.0\\ cm\\ isodense\\ mural\\ nodule\\ that\\ is\\ abutting\\ the\\ peripheral\\ leptomeninges\\,\\ and\\ shows\\ diffuse\\ enhancement\\.\\ \\ there\\ is\\ a\\ 5mm\\ focus\\ of\\ calcification\\ within\\ the\\ mural\\ nodule\\.\\ \\ there\\ is\\ associated\\ mass\\ effect\\ and\\ 1\\.2\\ cm\\ of\\ right\\ to\\ left\\ midline\\ shift\\.\\ \ \(0\)\
\-\ mr\\-\\ there\\ is\\ a\\ large\\ heterogeneous\\ cystic\\ mass\\ in\\ the\\ right\\ posterior\\ frontal\\-parietal\\ region\\.\\ \\ there\\ is\\ a\\ heterogeneous\\ mural\\ nodule\\ that\\ abuts\\ the\\ peripheral\\ leptomeninges\\,\\ and\\ demonstrates\\ avid\\ enhancement\\ after\\ gadolinium\\-dtpa\\ administration\\.\\ \\ again\\ identified\\ is\\ the\\ significant\\ mass\\ effect\\ and\\ associated\\ midline\\ shift\\ to\\ the\\ left\\.\ \(0\)\
\-\ pleomorphic\\ xanthoastrocytoma\ \(2\)\
\-\ pleomorphic\\ xanthoastrocytoma\ \(2\)\
\-\ pilocytic\\ astrocytoma\ \(31\)\
\-\ ganglioglioma\ \(14\)\
\-\ pnet\ \(0\)\
\-\ parasitic\\ cyst\\ \\(e\\.g\\.\\ racemose\\ cysticercosis\\)\ \(0\)\
\-\ 19\\ y\\.o\\ male\\ with\\ new\\ onset\\ emesis\\.\ \(1\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ frontal\\-parietal\\:\\ 0\\.08687028067814495\ \(0\)\
\-\ mural\\:\\ 0\\.07803649259976049\ \(0\)\
\-\ leptomeninges\\:\\ 0\\.07204360301910868\ \(0\)\
\-\ xanthoastrocytoma\\:\\ 0\\.06279229352727335\ \(0\)\
\-\ nodule\\:\\ 0\\.05650610052259903\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.051424441055978896\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.05040954796997336\ \(0\)\
\-\ effect\\:\\ 0\\.04853836769629805\ \(0\)\
\-\ \\~7\\.0\\:\\ 0\\.04714180975383154\ \(0\)\
\-\ survellience\\:\\ 0\\.043435140339072476\ \(0\)\
\-\ shift\\:\\ 0\\.04335127795902398\ \(0\)\
\-\ there\\:\\ 0\\.040803707694063815\ \(0\)\
\-\ gadolinium\\-dtpa\\:\\ 0\\.039728470924313405\ \(0\)\
\-\ racemose\\:\\ 0\\.038535189901242765\ \(0\)\
\-\ cm\\:\\ 0\\.036769349483694966\ \(0\)\
\-\ mr\\-\\:\\ 0\\.036735873127867295\ \(0\)\
\-\ midline\\:\\ 0\\.03535968007848685\ \(0\)\
\-\ cure\\:\\ 0\\.03431884038057822\ \(0\)\
\-\ 5\\.0\\:\\ 0\\.033425503029438294\ \(0\)\
\-\ peripheral\\:\\ 0\\.033068805583038687\ \(0\)\
\-\ abuts\\:\\ 0\\.03231513209479527\ \(0\)\
\-\ mass\\:\\ 0\\.03177703227132525\ \(0\)\
\-\ abutting\\:\\ 0\\.030612170965819155\ \(0\)\
\-\ ct\\-\\:\\ 0\\.030374461005547318\ \(0\)\
\-\ x\\:\\ 0\\.030150442089277828\ \(0\)\
\-\ 2\\.0\\:\\ 0\\.030146869484591186\ \(0\)\
\-\ avid\\:\\ 0\\.029718833614679228\ \(0\)\
\-\ mr\\:\\ 0\\.029039566544881646\ \(0\)\
\-\ isodense\\:\\ 0\\.028953588461520546\ \(0\)\
\-\ 5mm\\:\\ 0\\.0287782418154083\ \(0\)\
\-\ 1\\.2\\:\\ 0\\.0287782418154083\ \(0\)\
\-\ cysticercosis\\:\\ 0\\.028443908355615066\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.028284266841445648\ \(0\)\
\-\ parasitic\\:\\ 0\\.028284266841445648\ \(0\)\
\-\ pnet\\:\\ 0\\.027689477348877608\ \(0\)\
\-\ is\\:\\ 0\\.0270621230238638\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.026905501551060088\ \(0\)\
\-\ post\\-op\\:\\ 0\\.02678532585131646\ \(0\)\
\-\ cystic\\:\\ 0\\.026359708098949285\ \(0\)\
\-\ region\\:\\ 0\\.025813916868869653\ \(0\)\
\-\ emesis\\:\\ 0\\.025810344264183015\ \(0\)\
\-\ enhancement\\:\\ 0\\.024497206054791828\ \(0\)\
\-\ e\\.g\\:\\ 0\\.024198176378706453\ \(0\)\
\-\ pilocytic\\:\\ 0\\.024053638023690843\ \(0\)\
\-\ immediate\\:\\ 0\\.023912903754613978\ \(0\)\
\-\ contributory\\:\\ 0\\.023511646075774866\ \(0\)\
\-\ confirm\\:\\ 0\\.023259948156748204\ \(0\)\
\-\ need\\:\\ 0\\.0227895269110479\ \(0\)\
\-\ aggressive\\:\\ 0\\.022357162757951136\ \(0\)\
\-\ again\\:\\ 0\\.021957156270877885\ \(0\)\
\-\ associated\\:\\ 0\\.02156644451238184\ \(0\)\
\-\ 19\\:\\ 0\\.021071235832969767\ \(0\)\
\-\ posterior\\:\\ 0\\.021065652927298915\ \(0\)\
\-\ so\\:\\ 0\\.0207928595658251\ \(0\)\
\-\ focus\\:\\ 0\\.020528260329122586\ \(0\)\
\-\ large\\:\\ 0\\.01998441103562652\ \(0\)\
\-\ recurrence\\:\\ 0\\.019935412239219862\ \(0\)\
\-\ resolution\\:\\ 0\\.01970919630504505\ \(0\)\
\-\ good\\:\\ 0\\.01955327874198914\ \(0\)\
\-\ administration\\:\\ 0\\.01897144526686187\ \(0\)\
\-\ non\\:\\ 0\\.0188893833969439\ \(0\)\
\-\ measuring\\:\\ 0\\.01827462953181147\ \(0\)\
\-\ rate\\:\\ 0\\.017811344868854776\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.017745188228199444\ \(0\)\
\-\ within\\:\\ 0\\.0174345605174982\ \(0\)\
\-\ tumors\\:\\ 0\\.017164258597168455\ \(0\)\
\-\ calcification\\:\\ 0\\.0165870888687547\ \(0\)\
\-\ identified\\:\\ 0\\.016328700755007065\ \(0\)\
\-\ factoid\\:\\ 0\\.016018371623605008\ \(0\)\
\-\ new\\:\\ 0\\.015923999875938816\ \(0\)\
\-\ that\\:\\ 0\\.015785890145014154\ \(0\)\
\-\ less\\:\\ 0\\.01547561499637798\ \(0\)\
\-\ possible\\:\\ 0\\.015390279245369369\ \(0\)\
\-\ right\\:\\ 0\\.014464679825300805\ \(0\)\
\-\ onset\\:\\ 0\\.014424712438102406\ \(0\)\
\-\ will\\:\\ 0\\.014296689937856374\ \(0\)\
\-\ diffuse\\:\\ 0\\.013834264280081898\ \(0\)\
\-\ see\\:\\ 0\\.013637525193736835\ \(0\)\
\-\ y\\.o\\:\\ 0\\.013189194826666844\ \(0\)\
\-\ he\\:\\ 0\\.012749664930657857\ \(0\)\
\-\ a\\:\\ 0\\.012725127331078117\ \(0\)\
\-\ shows\\:\\ 0\\.012563495720475286\ \(0\)\
\-\ significant\\:\\ 0\\.012287952679434349\ \(0\)\
\-\ cyst\\:\\ 0\\.012280059550941724\ \(0\)\
\-\ these\\:\\ 0\\.01189221760405262\ \(0\)\
\-\ imaging\\:\\ 0\\.010706277136126216\ \(0\)\
\-\ left\\:\\ 0\\.010225724805057911\ \(0\)\
\-\ demonstrates\\:\\ 0\\.009981931559642705\ \(0\)\
\-\ have\\:\\ 0\\.009895390793396212\ \(0\)\
\-\ had\\:\\ 0\\.009860159461180257\ \(0\)\
\-\ but\\:\\ 0\\.009746006957398596\ \(0\)\
\-\ surgical\\:\\ 0\\.009605464012039858\ \(0\)\
\-\ after\\:\\ 0\\.009454551885610708\ \(0\)\
\-\ male\\:\\ 0\\.008263131218649588\ \(0\)\
\-\ to\\:\\ 0\\.0068513600284971065\ \(0\)\
\-\ an\\:\\ 0\\.006319063445372887\ \(0\)\
\-\ are\\:\\ 0\\.0062292720456128435\ \(0\)\
\-\ the\\:\\ 0\\.005914407901759392\ \(0\)\
\-\ and\\:\\ 0\\.004813075019578034\ \(0\)\
\-\ patient\\:\\ 0\\.00458070551292186\ \(0\)\
\-\ \\(\\:\\ 0\\.00386289693178535\ \(0\)\
\-\ \\)\\:\\ 0\\.00381570958349361\ \(0\)\
\-\ \\,\\:\\ 0\\.00289529481836671\ \(0\)\
\-\ \\.\\:\\ 0\\.00246788218858557\ \(0\)\
\-\ in\\:\\ 0\\.0022534611237446786\ \(0\)\
\-\ of\\:\\ 0\\.0018690449325880498\ \(0\)\
\-\ with\\:\\ 0\\.0006256907812293568\ \(0\)\
